User profiles for Robert W Yeh
 | Robert W. YehRichard and Susan Smith Center for Outcomes Research, Beth Israel Deaconess Medical … Verified email at stanfordalumni.org Cited by 101590 |
[HTML][HTML] Population trends in the incidence and outcomes of acute myocardial infarction
RW Yeh, S Sidney, M Chandra, M Sorel… - … England Journal of …, 2010 - Mass Medical Soc
Background Few studies have characterized recent population trends in the incidence and
outcomes of myocardial infarction. Methods We identified patients 30 years of age or older in …
outcomes of myocardial infarction. Methods We identified patients 30 years of age or older in …
Development and validation of a prediction rule for benefit and harm of dual antiplatelet therapy beyond 1 year after percutaneous coronary intervention
Importance Dual antiplatelet therapy after percutaneous coronary intervention (PCI) reduces
ischemia but increases bleeding. Objective To develop a clinical decision tool to identify …
ischemia but increases bleeding. Objective To develop a clinical decision tool to identify …
Heart disease and stroke statistics—2016 update: a report from the American Heart Association
…, A Towfighi, TN Turan, SS Virani, D Woo, RW Yeh… - circulation, 2016 - Am Heart Assoc
Each year, the American Heart Association (AHA), in conjunction with the Centers for Disease
Control and Prevention, the National Institutes of Health, and other government agencies, …
Control and Prevention, the National Institutes of Health, and other government agencies, …
Community-Level Factors Associated With Racial And Ethnic Disparities In COVID-19 Rates In Massachusetts: Study examines community-level factors associated …
Massachusetts has one of the highest cumulative incidence rates of coronavirus disease 2019
(COVID-19) cases in the US. Understanding which specific demographic, economic, and …
(COVID-19) cases in the US. Understanding which specific demographic, economic, and …
Benefits and risks of extended duration dual antiplatelet therapy after PCI in patients with and without acute myocardial infarction
Background : The benefits and risks of prolonged dual antiplatelet therapy may be different
for patients with acute myocardial infarction (MI) compared with more stable presentations. …
for patients with acute myocardial infarction (MI) compared with more stable presentations. …
Parachute use to prevent death and major trauma when jumping from aircraft: randomized controlled trial
… Robert W Yeh,1 Linda R Valsdottir,1 Michael W Yeh,2 Changyu Shen,1 Daniel B Kramer,1
Jordan B Strom,1 Eric A Secemsky,1 Joanne L Healy,1 Robert M Domeier,3 Dhruv S Kazi,1 …
Jordan B Strom,1 Eric A Secemsky,1 Joanne L Healy,1 Robert M Domeier,3 Dhruv S Kazi,1 …
Heart disease and stroke statistics—2015 update: a report from the American Heart Association
…, TN Turan, SS Virani, JZ Willey, D Woo, RW Yeh… - circulation, 2015 - Am Heart Assoc
Each year, the American Heart Association (AHA), in conjunction with the Centers for Disease
Control and Prevention, the National Institutes of Health, and other government agencies, …
Control and Prevention, the National Institutes of Health, and other government agencies, …
Lesion complexity and outcomes of extended dual antiplatelet therapy after percutaneous coronary intervention
Background : Subjects undergoing coronary stenting with complex lesion anatomy may
experience different risks and benefits with prolonged dual antiplatelet therapy. Objectives : The …
experience different risks and benefits with prolonged dual antiplatelet therapy. Objectives : The …
[HTML][HTML] Twelve or 30 months of dual antiplatelet therapy after drug-eluting stents
L Mauri, DJ Kereiakes, RW Yeh… - … England Journal of …, 2014 - Mass Medical Soc
Background Dual antiplatelet therapy is recommended after coronary stenting to prevent
thrombotic complications, yet the benefits and risks of treatment beyond 1 year are uncertain. …
thrombotic complications, yet the benefits and risks of treatment beyond 1 year are uncertain. …
Defining high bleeding risk in patients undergoing percutaneous coronary intervention: a consensus document from the Academic Research Consortium for High …
Identification and management of patients at high bleeding risk undergoing percutaneous
coronary intervention are of major importance, but a lack of standardization in defining this …
coronary intervention are of major importance, but a lack of standardization in defining this …
